Dr. Charles Sneiderman reviews the clinical practice guidelines for preventive services recommended for primary care providers and indicates that the guidelines of the Federal Department of Health and Human Services are the standard for reimbursable preventive care.
This activity will provide the attendee with the latest up-to-date information and state-of-the-art management strategies using oral antiplatelet drugs for Acute Coronary Syndrome patients based on the 2013 ACC/AHA Guidelines.
This educational activity will discuss appropriate screening and assessment for glycemia and associated comorbidities and review safety, efficacy, mechanisms of action, and place for non-insulin therapies within the treatment algorithm.
This activity was developed from the live Best Practices in Primary Care™ program held in Chicago, Illinois on June 21, 2014. The expert faculty will discuss the strategies pertaining to appropriate initiation and intensification of insulin therapy.
Hypogonadism is an underdiagnosed syndrome with links to age, obesity, type 2 diabetes mellitus (T2DM), and metabolic syndromes. This activity will help clinicians with appropriate screening, diagnosis, and available testosterone supplemental therapies.
The ACC/AHA guidelines has 9 recommendations for hypertension. Dr. Charles Sneiderman reviews the new guidelines published in 2014 by the National Institutes of Health eighth Joint National Committee (JNC8).
Rethinking the Utility of Beta-blockers. It may be time to rethink the long-term use of beta-blockers in your patients with a history of cardiovascular disease. Among patients who have: 1) risk factors for coronary artery disease (CAD), 2) have suffered a prior heart attack, or 3) who have CAD without heart attack, the use of beta-blockers was not associated with a lower risk of a composite of cardiovascular events, according to a new study published in JAMA.
Helping Clinicians and Patients Eliminate Unnecessary Tests and Procedures. The American Board of Internal Medicine Foundation, nine U.S. specialty medical societies, and Consumer Reports have partnered in a new initiative called Choosing Wise™.
New Clinicial Practice Guideline for Treating Acute Sinus Infections. The IDSA has released a clinical practice guideline on the management of acute bacterial rhinosinusitis in children and adults. Nearly one in seven people are diagnosed with a sinus infection each year. Although sinus infections are the fifth leading reason for antibiotic prescriptions, 90% to 98% of cases are caused by viruses, which are not affected by antibiotics.
When Younger Women Have a Heart Attack. According to a new study published in JAMA, younger women who seek out medical care for a myocardial infarction (MI) are more likely to present at the hospital without chest pain and are also more likely to die in the hospital following a heart attack
Acute Sinusitis—Antibiotics, or Watch and Wait? A recent article in JAMA suggests that among 133 adults with uncomplicated rhinosinusitis, treatment with amoxicillin resulted in no significant difference in symptoms compared with placebo.
“Quitting smoking is easy. I’ve done it a thousand times”—Mark Twain. At this time of year, many of your patients are likely to make a resolution to stop smoking. But like all good intentions that go awry, patients may need your support and encouragement to help them through the physiologic and psychological barriers they face in quitting. Many of them are also likely to ask you about the latest trend in smoking cessation aids—electronic cigarettes.